PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $4.4 million in its fiscal second quarter.

The Pittsburgh-based company said it had a loss of 26 cents per share.

NeuBase shares have risen 14% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.18, more than tripling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE

Automated Insights, source Associated Press News